Cargando…

The role of complement factor H in gestational diabetes mellitus and pregnancy

BACKGROUND: Complement factor H (CFH) has been found to be associated with insulin resistance. This study assessed the correlation between CFH and other clinical parameters, and determined whether CFH played a role in gestational diabetes mellitus (GDM) and adverse pregnancy outcomes. METHODS: A tot...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Junxian, Shen, Ying, Tian, Hairong, Xie, Shuting, Ji, Ye, Li, Ziyun, Lu, Junxi, Lu, Huijuan, Liu, Bo, Liu, Fang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8369714/
https://www.ncbi.nlm.nih.gov/pubmed/34404360
http://dx.doi.org/10.1186/s12884-021-04031-w
_version_ 1783739344796778496
author Li, Junxian
Shen, Ying
Tian, Hairong
Xie, Shuting
Ji, Ye
Li, Ziyun
Lu, Junxi
Lu, Huijuan
Liu, Bo
Liu, Fang
author_facet Li, Junxian
Shen, Ying
Tian, Hairong
Xie, Shuting
Ji, Ye
Li, Ziyun
Lu, Junxi
Lu, Huijuan
Liu, Bo
Liu, Fang
author_sort Li, Junxian
collection PubMed
description BACKGROUND: Complement factor H (CFH) has been found to be associated with insulin resistance. This study assessed the correlation between CFH and other clinical parameters, and determined whether CFH played a role in gestational diabetes mellitus (GDM) and adverse pregnancy outcomes. METHODS: A total of 397 pregnant women were included for analysis in this nested case-control study. Clinical parameters and serum were collected within the 11-17th gestational age at the first prenatal visit. At 24–28 weeks of gestation, a 75 g oral glucose tolerance test was performed and subjects were divided into a GDM (n = 80) and a non-GDM control group (n = 317). The delivery data were also followed. The serum CFH level was assayed by ELISA. RESULTS: CFH was higher in GDM than in non-GDM controls (280.02 [58.60] vs. 264.20 [68.77]; P = 0.014). CFH level was moderately associated with pre-pregnancy body mass index (BMI), BMI and total triglycerides (TG), and slightly associated with gestational age, low density lipoprotein cholesterol (LDL-C), total cholesterol (TC) in GDM and non-GDM (all P <  0.05). Moreover, CFH level was moderately correlated with alkaline phosphatase (ALP) and slightly correlated with age, uric acid (UA) and total bilirubin (TB) in non-GDM (all P <  0.05). After adjustment for clinical confounding factors, BMI, TG, gestational age, ALP, TB, age and UA were independent risk factors for log(10) CFH levels (all P <  0.05) in all subjects. In addition, overweight or obese pregnant women, women with hypertriglyceridemia and women in the second trimester had significantly higher CFH levels than normal weight and underweight group (P <  0.001), the non-hypertriglyceridemia group (P <  0.001) and women in the first trimester group (P < 0.05) in all pregnant women respectively. Following binary logistic regression, CFH was not independently associated with GDM and related pregnant outcomes. CONCLUSIONS: The CFH in 11-17th weeks of gestation might be affected by many factors, including BMI, TG, gestational age, ALP, TB, age and UA. CFH was not an independent risk factor for GDM and avderse pregnancy outcomes. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12884-021-04031-w.
format Online
Article
Text
id pubmed-8369714
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-83697142021-08-18 The role of complement factor H in gestational diabetes mellitus and pregnancy Li, Junxian Shen, Ying Tian, Hairong Xie, Shuting Ji, Ye Li, Ziyun Lu, Junxi Lu, Huijuan Liu, Bo Liu, Fang BMC Pregnancy Childbirth Research Article BACKGROUND: Complement factor H (CFH) has been found to be associated with insulin resistance. This study assessed the correlation between CFH and other clinical parameters, and determined whether CFH played a role in gestational diabetes mellitus (GDM) and adverse pregnancy outcomes. METHODS: A total of 397 pregnant women were included for analysis in this nested case-control study. Clinical parameters and serum were collected within the 11-17th gestational age at the first prenatal visit. At 24–28 weeks of gestation, a 75 g oral glucose tolerance test was performed and subjects were divided into a GDM (n = 80) and a non-GDM control group (n = 317). The delivery data were also followed. The serum CFH level was assayed by ELISA. RESULTS: CFH was higher in GDM than in non-GDM controls (280.02 [58.60] vs. 264.20 [68.77]; P = 0.014). CFH level was moderately associated with pre-pregnancy body mass index (BMI), BMI and total triglycerides (TG), and slightly associated with gestational age, low density lipoprotein cholesterol (LDL-C), total cholesterol (TC) in GDM and non-GDM (all P <  0.05). Moreover, CFH level was moderately correlated with alkaline phosphatase (ALP) and slightly correlated with age, uric acid (UA) and total bilirubin (TB) in non-GDM (all P <  0.05). After adjustment for clinical confounding factors, BMI, TG, gestational age, ALP, TB, age and UA were independent risk factors for log(10) CFH levels (all P <  0.05) in all subjects. In addition, overweight or obese pregnant women, women with hypertriglyceridemia and women in the second trimester had significantly higher CFH levels than normal weight and underweight group (P <  0.001), the non-hypertriglyceridemia group (P <  0.001) and women in the first trimester group (P < 0.05) in all pregnant women respectively. Following binary logistic regression, CFH was not independently associated with GDM and related pregnant outcomes. CONCLUSIONS: The CFH in 11-17th weeks of gestation might be affected by many factors, including BMI, TG, gestational age, ALP, TB, age and UA. CFH was not an independent risk factor for GDM and avderse pregnancy outcomes. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12884-021-04031-w. BioMed Central 2021-08-17 /pmc/articles/PMC8369714/ /pubmed/34404360 http://dx.doi.org/10.1186/s12884-021-04031-w Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Li, Junxian
Shen, Ying
Tian, Hairong
Xie, Shuting
Ji, Ye
Li, Ziyun
Lu, Junxi
Lu, Huijuan
Liu, Bo
Liu, Fang
The role of complement factor H in gestational diabetes mellitus and pregnancy
title The role of complement factor H in gestational diabetes mellitus and pregnancy
title_full The role of complement factor H in gestational diabetes mellitus and pregnancy
title_fullStr The role of complement factor H in gestational diabetes mellitus and pregnancy
title_full_unstemmed The role of complement factor H in gestational diabetes mellitus and pregnancy
title_short The role of complement factor H in gestational diabetes mellitus and pregnancy
title_sort role of complement factor h in gestational diabetes mellitus and pregnancy
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8369714/
https://www.ncbi.nlm.nih.gov/pubmed/34404360
http://dx.doi.org/10.1186/s12884-021-04031-w
work_keys_str_mv AT lijunxian theroleofcomplementfactorhingestationaldiabetesmellitusandpregnancy
AT shenying theroleofcomplementfactorhingestationaldiabetesmellitusandpregnancy
AT tianhairong theroleofcomplementfactorhingestationaldiabetesmellitusandpregnancy
AT xieshuting theroleofcomplementfactorhingestationaldiabetesmellitusandpregnancy
AT jiye theroleofcomplementfactorhingestationaldiabetesmellitusandpregnancy
AT liziyun theroleofcomplementfactorhingestationaldiabetesmellitusandpregnancy
AT lujunxi theroleofcomplementfactorhingestationaldiabetesmellitusandpregnancy
AT luhuijuan theroleofcomplementfactorhingestationaldiabetesmellitusandpregnancy
AT liubo theroleofcomplementfactorhingestationaldiabetesmellitusandpregnancy
AT liufang theroleofcomplementfactorhingestationaldiabetesmellitusandpregnancy
AT lijunxian roleofcomplementfactorhingestationaldiabetesmellitusandpregnancy
AT shenying roleofcomplementfactorhingestationaldiabetesmellitusandpregnancy
AT tianhairong roleofcomplementfactorhingestationaldiabetesmellitusandpregnancy
AT xieshuting roleofcomplementfactorhingestationaldiabetesmellitusandpregnancy
AT jiye roleofcomplementfactorhingestationaldiabetesmellitusandpregnancy
AT liziyun roleofcomplementfactorhingestationaldiabetesmellitusandpregnancy
AT lujunxi roleofcomplementfactorhingestationaldiabetesmellitusandpregnancy
AT luhuijuan roleofcomplementfactorhingestationaldiabetesmellitusandpregnancy
AT liubo roleofcomplementfactorhingestationaldiabetesmellitusandpregnancy
AT liufang roleofcomplementfactorhingestationaldiabetesmellitusandpregnancy